IPG Investment Advisors LLC Invests $1.94 Million in DaVita Inc. $DVA

IPG Investment Advisors LLC acquired a new stake in DaVita Inc. (NYSE:DVA) in the second quarter, Holdings Channel.com reports. The fund acquired 8,712 shares of the company’s stock, valued at approximately $1,938,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Value Investment Professionals LLC increased its holdings in shares of DaVita by 2.0% during the 2nd quarter. Value Investment Professionals LLC now owns 2,501 shares of the company’s stock worth $556,000 after buying an additional 50 shares during the last quarter. Kesler Norman & Wride LLC increased its stake in DaVita by 0.8% during the first quarter. Kesler Norman & Wride LLC now owns 6,816 shares of the company’s stock worth $1,048,000 after acquiring an additional 55 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in DaVita by 4.1% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,915 shares of the company’s stock valued at $426,000 after purchasing an additional 76 shares during the period. Gen Wealth Partners Inc lifted its stake in shares of DaVita by 10.0% in the 4th quarter. Gen Wealth Partners Inc now owns 880 shares of the company’s stock valued at $100,000 after purchasing an additional 80 shares during the last quarter. Finally, NewEdge Advisors LLC grew its holdings in shares of DaVita by 20.8% during the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock worth $78,000 after purchasing an additional 88 shares during the period. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DVA has been the topic of a number of recent analyst reports. Raymond James Financial set a $220.00 target price on shares of DaVita in a research report on Friday, August 7th. Barclays boosted their price target on shares of DaVita from $218.00 to $224.00 and gave the company an “equal weight” rating in a research note on Wednesday, August 5th. UBS Group upped their price objective on shares of DaVita from $235.00 to $270.00 and gave the stock a “buy” rating in a report on Friday, July 10th. Oppenheimer set a $220.00 target price on shares of DaVita in a report on Friday, August 7th. Finally, Truist Financial cut their target price on DaVita from $250.00 to $215.00 and set a “hold” rating on the stock in a research report on Friday, August 7th. Four analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $233.43.

Insider Transactions at DaVita

In other news, insider Kathleen Waters sold 15,405 shares of DaVita stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $208.40, for a total value of $3,210,402.00. Following the completion of the transaction, the insider owned 109,194 shares in the company, valued at approximately $22,756,029.60. This trade represents a 12.36% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.90% of the stock is owned by corporate insiders.

DaVita Stock Up 1.7%

DaVita stock opened at $183.11 on Thursday. DaVita Inc. has a 52-week low of $101.00 and a 52-week high of $247.49. The firm has a market cap of $11.68 billion, a PE ratio of 14.98, a price-to-earnings-growth ratio of 0.47 and a beta of 0.83. The company’s 50 day moving average is $206.15 and its two-hundred day moving average is $185.25.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $4.02 earnings per share for the quarter, topping analysts’ consensus estimates of $3.88 by $0.14. The business had revenue of $3.55 billion for the quarter, compared to analyst estimates of $3.50 billion. DaVita had a negative return on equity of 217.63% and a net margin of 6.05%.The company’s revenue was up 5.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.95 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. On average, equities research analysts anticipate that DaVita Inc. will post 14.57 earnings per share for the current fiscal year.

DaVita Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.